British Journal of Clinical Pharmacology · 1983 · 11 citations · 24 references
MedicinePharmacologyPharmacotherapyCardiovascular PharmacotherapyClinical PharmacologyPharmacodynamicsCerebral Blood FlowCerebrovascular PhysiologyHemodynamic PharmacologyPlatelet PhysiologyAdenosine Diphosphate-induced Platelet AggregationBlood PressureCardiac OutputCerebral Blood Flow AlterationsCerebral Blood Flow EffectsCerebral Blood Flow RegulationProstaglandin PharmacologyProstaglandin-mediated Vasodilation
Epoprostenol (prostacyclin, PGI2) was given intravenously to seven healthy volunteers in a dose of 4 ng kg-1 min-1 over a 30 min period. Diastolic blood pressure fell but there was no change in cardiac output. The mean PGI2 concentration at the end of the infusion was 0.43 ng/ml (1.1 nM) and a significant inhibition of ADP-induced platelet aggregation occurred. Although obvious facial flushing occurred in all subjects and some subjects complained of headache, cerebral blood flow tended to fall. The results do not support the hypothesis that PGI2 acts as a physiological vasodilator involved in the homeostasis of normal cerebral blood flow.
24
J. M. Armstrong, Norman Lattimer, Salvador Moncada et al. · British Journal of Pharmacology · 1978 · 278 citations · Full text
SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN
Andrzej Szczeklik, S Skawiński, Rafał Niżankowski et al. · The Lancet · 1979 · 277 citations
D J Boullin, S Bunting, WP Blaso et al. · British Journal of Clinical Pharmacology · 1979 · 142 citations · Full text